Abstract
Taxol is a potent stabilizer of microtubules, and inhibitor of in vitro replication, migration, and contraction of fibroblasts. It has been found to limit the development of experimental tractional retinal detachments in nonvitrectomized rabbit eyes. We used taxol in vitrectomized, phakic rabbit eyes with experimentally induced proliferative vitreoretinopathy and tractional retinal detachments. Taxol was dissolved in 30% DMSO because of poor aqueous solubility. A single 0.1 ml intravitreal dose of 2 × 10−4 M taxol in 30% DMSO was injected immediately after 250000 heterologous corneal fibroblasts had been injected; 0.1 ml of 30% DMSO was injected into control eyes. Taxol reduced the incidence of tractional retinal detachments seen 3–4 weeks later. When taxol injection was delayed for 3 days after the initial intravitreal injection of fibroblasts into nonvitrectomized eyes, the extent of retinal detachments was reduced, but the incidence of retinal detachment was unchanged from the untreated eyes at the end of 4 weeks. These data indicate that taxol may be most useful when given early in the course of proliferative vitreoretinopathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (eds) (1983) Molecular biology of the cell. Garland, New York, pp 611–621
Blumenkranz MS, Ophir A, Claflin AJ, Hajek A (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467
Blumenkranz M, Hernandez E, Ophir A, Norton EWD (1984) 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91:122–129
Darnell J, Lodish H, Baltimore D (1986) Molecular cell biology. Scientific American Books, Freeman, New York, pp 147–148
Fastenberg DM, Diddie KR, Dorey K, Ryan SJ (1982) The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol 93:565–572
Hsu HT, Dorey K, Sorgente N, Ryan SJ (1984) Surgical removal of vitreous: its effect on intraocular fibroblast proliferation in the rabbit. Arch Ophthalmol 120:605–607
Kirmani M, Santana M, Sorgente N, Wiedemann P, Ryan SJ (1983) Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy: control by daunomycin. Retina 3:269–272
Lemor M, Yeo JH, Glaser BM (1986) Oral colchicine for the treatment of experimental retinal detachment. Arch Ophthalmol 104:1226–1229
Retina Society Terminology Committee (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121–125
Schepens CL (1983) Retinal detachment and allied diseases. Saunders, Philadelphia, pp 497–498
Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561–1565
Silverman CA, Yoshizumi MO (1984) Ocular toxicity of experimental intravitreal DMSO. J Toxicol-Cut & Ocular Toxicol 2(2&3):193–200
Stern WH, Lewis GP, Erickson PA, Guering CJ, Anderson DH, Fisher SK, O'Donnell JJ (1983) Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am J Ophthalmol 96:33–42
Swinscow TDV (1982) Statistics at square one. British Medical Association, London, pp 30–32
Tano Y, Chandler D, Machemer R (1980) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816
Tano Y, Chandler DB, McCuen BW, Machemer R (1981) Glucocorticosteroid inhibition of intraocular proliferation after injury. Am J Ophthalmol 91:184–189
Tokunaka S, Friedman TM, Toyama Y, Pacifici M, Holtzer H (1983) Taxol induces microtubule-rough endoplasmic reticulum complexes and microtubule-bundles in cultured chondroblasts. Differentiation 24:39–47
Van Bockxmeer FM, Martin CE, Thompson DE, Constable IJ (1984) Taxol in the treatment of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26:1140–1147
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent fromTaxus brevifolia. J Am Chem Soc 93:2325–2327
Author information
Authors and Affiliations
Additional information
Dr. Stewart Daniels was an Abe Meyer Fellow
Rights and permissions
About this article
Cite this article
Daniels, S.A., Coonley, K.G. & Yoshizumi, M.O. Taxol treatment of experimental proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 228, 513–516 (1990). https://doi.org/10.1007/BF00918482
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918482